Angiotensin Converting Enzymes (ACE) Inhibitors Market Size, Trends, Shares, Insights Forecast 2027

ANGIOTENSIN CONVERTING ENZYMES (ACE) INHIBITORS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027

© Coherent market Insights. All Rights Reserved

REPORT DESCRIPTION Angiotensin Converting Enzymes (ACE) Inhibitors Market - Overview The Global Angiotensin Converting Enzymes (ACE) Inhibitors Market, by Drugs (Benazepril, Perindopril, Trandfolapril, Captopril, Enalapril, Lisinopril, Ramipril, and Others), by Application (Hypertension, Coronary Artery Disease, Heart Failure, Chronic Kidney Disease, Scleroderma, and Migraine), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 11,693.6 million in 2017, and is projected to exhibit a CAGR of 0.8%, during the forecast period (2018 - 2026), as highlighted in a new report published by.

Increasing product launches for ACE inhibitor drug class is expected to boost the angiotensin converting enzymes (ACE) inhibitors market growth. For instance, in February 2014, Martindale Pharma, launched new Captopril oral liquid solution for the treatment of chronic heart failure in newborns, infants, and children. Captopril, an angiotensin converting enzyme (ACE) inhibitor, is widely used for the treatment of hypertension, congestive heart failure, and kidney problems. Captopril is responsible for conversion of Angiotensin I to Angiotensin II. Through this conversion, Captopril helps to maintain blood pressure of the body. Increasing drug approvals from healthcare regulatory authorities for the treatment of hypertension is expected to drive the market growth. For instance, in March 2018, January 2015, the U.S. Food and Drug Administration (FDA) approved Perindopril Erbumine tablet for the treatment of high blood pressure (hypertension).

Browse Research Reports: https://www.coherentmarketinsights.com/marketinsight/angiotensin-converting-enzymes-ace-inhibitors-market-2746 Š Coherent market Insights. All Rights Reserved

REPORT DESCRIPTION Browse 23 Market Data Tables and 19 Figures spread through 163 Pages and in-depth TOC on "Angiotensin Converting Enzymes (ACE) Inhibitors Market, by Drugs (Benazepril, Perindopril, Trandfolapril, Captopril, Enalapril, Lisinopril, Ramipril, and Others), by Application (Hypertension, Coronary Artery Disease, Heart Failure, Chronic Kidney Disease, Scleroderma, and Migraine), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) Key players in the market are focused on launching new products for the treatment of hypertension. For instance, in July 2018, Pharmascience Inc. launched Trandolapril (ACE inhibitor) for the treatment of mild to moderate hypertension. In the case of mild to moderate hypertension, the drug can be used alone or in combination with thiazide diuretics.

Trandolapril is also used for the treatment of myocardial infraction. Moreover, in January 2017, Silvergate Pharmaceuticals, Inc. launched Epaned (containing Enalapril), an oral solution, for the treatment of hypertension, symptomatic heart failure, and asymptomatic left ventricular dysfunction in adult and children. Therefore, increasing launch of new products is expected to support growth of the ACE inhibitors market. Increasing number of studies related to ACE inhibitors for the treatment of hypertension is also expected to propel the market growth during the forecast period. For instance, in February 2018, University of Munich initiated clinical phase III study to determine the effects of amlodipine and other blood pressure lowering agents (such as Losartan and Atenolol) on micro vascular function in small vessel disease. This study is expected to complete in September 2020.

Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2746 Š Coherent market Insights. All Rights Reserved

REPORT DESCRIPTION Key Takeaways of the Angiotensin Converting Enzymes (ACE) Inhibitors Market: The global angiotensin converting enzymes (ACE) inhibitors market is expected to witness a CAGR of 0.8% during the forecast period (2018 – 2026), owing to increasing product launch for the treatment of hypertension and congestive heart failure Among regions, North America is expected account for the largest market share in the angiotensin converting enzymes (ACE) inhibitors market. Increasing prevalence of hypertension is expected to boost the market growth in the region. For instance, according to American Heart Association (AHA), January 2018, per year 100 million people suffer from hypertension in the U.S. Major players operating in the global angiotensin converting enzymes (ACE) inhibitors market, include, Pfizer, Inc., AstraZeneca Pharmaceutical Company, Novartis AG, Daiichi Sankyo Company, Ltd., United Therapeutics Corporation, Sanofi S.A., Johnson & Johnson Services, Inc., Merck KGaA, Takeda Pharmaceutical Company, and Bayer AG.

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2746 Š Coherent market Insights. All Rights Reserved

ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.

SERVICES INDUSTRY ANALYSIS

CUSTOMIZED RESEARCH

SYNDICATED RESEARCH

MARKET INTELLIGENCE SERVICES

CONSULT STUDIES

COUNTRY SPECIFIC STUDIES

Š Coherent market Insights. All Rights Reserved

ABOUT CMI SECTOR COVERAGE

BIOTECHNOLOGY

CLINICAL DIAGNOSTIC

HEALTHCARE IT

MEDICAL DEVICES

MEDICAL IMAGING

PHARMACEUTICAL

OUR CLIENTS

 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry

 Component Providers and System Integrators

 Private and Government organization

 Distributors, Retailors and Value Added Resellers

 Outsourcing Companies

 Healthcare IT Solutions Developers

 Universities and Business Schools.

© Coherent market Insights. All Rights Reserved

KEY STATS

RESEARCH SOLUTIONS

100+

FEASIBILITY STUDIES

Insights Published Per Year

GLOBAL REPORTS

150+

Consulting Projects Till Date

COUNTRY ANALYSIS CONSULT PROJECTS

125+

Clients Worldwide Per Year

110+

SURVEY RESEARCH

EXCEL FORECAST DATABASE

CUSTOMIZED SOLUTIONS

COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS

Analysts and Contract Consultants

Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702

Š Coherent market Insights. All Rights Reserved